Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 18,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · derivative · entry 12 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,356 Underlying: Common Stock · 18,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F9 · shares: Includes 1991 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F10 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F10 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F9 · derivative.underlying_shares: Includes 1991 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 25,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · derivative · entry 11 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,494 Underlying: Common Stock · 25,493 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F7 · shares: Includes 2719 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F8 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F8 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F7 · derivative.underlying_shares: Includes 2719 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 18,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · derivative · entry 10 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,151 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · shares: Includes 1935 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F6 · derivative.exercise_date: The Restricted Stock Units vested in three installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification that MetLife, Inc. met specified financial goals. F6 · derivative.expiration_date: The Restricted Stock Units vested in three installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification that MetLife, Inc. met specified financial goals. F5 · derivative.underlying_shares: Includes 1935 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 24,834 | $45.50 | $1,129,947.00 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 8 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,922.9527 F4 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantCommon Stock | 50,424 | $45.50 | $2,294,292.00 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 7 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,756.9527 F3 · kind: Shares acquired from the payout of the 2015-2017 Performance Share Award following determination of the performance factor for such award. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 9,199 | $45.50 | $418,554.50 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 6 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,332.9527 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 18,677 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 5 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,531.9527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 11,982 | $45.50 | $545,181.00 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 4 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,854.9527 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 25,493 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 3 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,836.9527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 6,217 | $45.50 | $282,873.50 |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 2 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,343.9527 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:39 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 18,151 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017293 · doc4.xml · nonDerivative · entry 1 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,560.9527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 9,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · derivative · entry 13 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,231 Underlying: Common Stock · 9,231 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F12 · derivative.exercise_date: The Restricted Stock Units vest in three installments on the first business day in March 2019, 2020 and 2021. F12 · derivative.expiration_date: The Restricted Stock Units vest in three installments on the first business day in March 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 27,687 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · derivative · entry 12 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,687 Underlying: Common Stock · 27,687 shares Expires 2028-03-01 F11 · derivative.exercise_date: The options become exercisable in three equal installments on March 2, 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · derivative · entry 11 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,674 Underlying: Common Stock · 5,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F9 · shares: Includes 569 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F10 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F10 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F9 · derivative.underlying_shares: Includes 569 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · derivative · entry 10 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,285 Underlying: Common Stock · 7,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F7 · shares: Includes 776 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F8 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F8 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F7 · derivative.underlying_shares: Includes 776 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · derivative · entry 9 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · shares: Includes 580 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F6 · derivative.exercise_date: The Restricted Units vested in three installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification that MetLife, Inc. met specified financial goals. F6 · derivative.expiration_date: The Restricted Units vested in three installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification that MetLife, Inc. met specified financial goals. F5 · derivative.underlying_shares: Includes 580 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 7,465 | $45.50 | $339,657.50 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 8 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,200 F4 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
GrantCommon Stock | 15,128 | $45.50 | $688,324.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 7 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,665 F3 · kind: Shares acquired from the payout of 2015-2017 Performance Share Award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,040 | $45.50 | $92,820.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 6 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,537 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 5 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,784 | $45.50 | $126,672.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 4 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,241 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 3 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,070 | $45.50 | $94,185.00 |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 2 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,742 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:38 UTC |
Hele John C.R.EVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017287 · doc4.xml · nonDerivative · entry 1 Hele John C.R. · CIK 0001460835 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:37 UTC |
GAUSTER STEPHEN WSVP & Interim General Counsel
|
GrantRestricted Stock Units · Derivative | 5,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017279 · doc4.xml · derivative · entry 4 GAUSTER STEPHEN W · CIK 0001709219 · SVP & Interim General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,495 Underlying: Common Stock · 5,495 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. F5 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:37 UTC |
GAUSTER STEPHEN WSVP & Interim General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017279 · doc4.xml · derivative · entry 3 GAUSTER STEPHEN W · CIK 0001709219 · SVP & Interim General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,278 Underlying: Common Stock · 1,138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 121 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F3 · derivative.underlying_shares: Includes 121 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:37 UTC |
GAUSTER STEPHEN WSVP & Interim General Counsel
|
Tax withholdingCommon Stock | 496 | $45.50 | $22,568.00 |
DisclosureSEC source: 0001209191-18-017279 · doc4.xml · nonDerivative · entry 2 GAUSTER STEPHEN W · CIK 0001709219 · SVP & Interim General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:37 UTC |
GAUSTER STEPHEN WSVP & Interim General Counsel
|
Exercise / conversionCommon Stock | 1,138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017279 · doc4.xml · nonDerivative · entry 1 GAUSTER STEPHEN W · CIK 0001709219 · SVP & Interim General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 21:27 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock Equivalent Units · Derivative | 73.8219 | $46.89 | $3,461.51 |
DisclosureSEC source: 0001209191-18-013356 · doc4.xml · derivative · entry 3 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73.8219 Underlying: Common Stock · 73.8219 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: These Common Stock Equivalent Units were credited on February 23, 2018, effective February 20, 2018. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:25 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 185 | $46.89 | $8,674.65 |
DisclosureSEC source: 0001209191-18-012419 · doc4.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. This is a pro-rata amount for the period from February 20, 2018 to March 31, 2018. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 21:16 UTC |
Lee EstherEVP & Chief Marketing Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 17,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-003933 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 1,893 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F4 · derivative.exercise_date: The Restricted Stock Units were granted on January 12, 2015, and vested on January 12, 2018. F4 · derivative.expiration_date: The Restricted Stock Units were granted on January 12, 2015, and vested on January 12, 2018. F3 · derivative.underlying_shares: Includes 1,893 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 21:16 UTC |
Lee EstherEVP & Chief Marketing Officer
|
Tax withholdingCommon Stock | 7,412 | $53.33 | $395,281.96 |
DisclosureSEC source: 0001209191-18-003933 · doc4.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,596 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 21:16 UTC |
Lee EstherEVP & Chief Marketing Officer
|
GrantCommon Stock | 17,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-003933 · doc4.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,008 F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:22 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001950 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,170.2472 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:21 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001948 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,420.9185 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:22 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001953 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,209 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:20 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001943 · doc4.xml · nonDerivative · entry 1 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,915.0824 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:20 UTC |
Kennard William EDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001945 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,666.3639 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:19 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001941 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,084.1196 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:18 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalent Units · Derivative | 498.2065 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-001936 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498.2065 Underlying: Common Stock · 498.2065 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F2 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:18 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001936 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,183.9485 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:18 UTC |
Herzog David LDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001931 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,260 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:17 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001929 · doc4.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,650 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:17 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001924 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,073.0631 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:21 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 184.5999 | $52.84 | $9,754.26 |
DisclosureSEC source: 0001209191-17-065919 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,422.2472 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:21 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock Equivalent Units · Derivative | 83.2111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-065917 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83.2111 Underlying: Common Stock · 83.2111 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:21 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 348.5718 | $52.84 | $18,418.53 |
DisclosureSEC source: 0001209191-17-065917 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,672.9185 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:20 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 225.7632 | $52.84 | $11,929.33 |
DisclosureSEC source: 0001209191-17-065915 · doc4.xml · nonDerivative · entry 1 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,167.0824 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:20 UTC |
Kennard William EDirector
|
GrantCommon Stock | 104.5707 | $52.84 | $5,525.52 |
DisclosureSEC source: 0001209191-17-065916 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,918.3639 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:19 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 70.1436 | $52.84 | $3,706.39 |
DisclosureSEC source: 0001209191-17-065912 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,336.1196 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.